BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7585137)

  • 1. Identifying the killer in cystic fibrosis.
    Hearst JE; Elliott KE
    Nat Med; 1995 Jul; 1(7):626-7. PubMed ID: 7585137
    [No Abstract]   [Full Text] [Related]  

  • 2. Virulence factors of Burkholderia cepacia.
    Nelson JW; Butler SL; Krieg D; Govan JR
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):89-97. PubMed ID: 7513590
    [No Abstract]   [Full Text] [Related]  

  • 3. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.
    Sun L; Jiang RZ; Steinbach S; Holmes A; Campanelli C; Forstner J; Sajjan U; Tan Y; Riley M; Goldstein R
    Nat Med; 1995 Jul; 1(7):661-6. PubMed ID: 7585148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mounting a defense against Burkholderia cepacia.
    Godshall M
    Nursing; 2005 May; 35(5):18-9. PubMed ID: 15879939
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis.
    Dettelbach MA; Hirsch BE; Weissman JL
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):528-32. PubMed ID: 7524007
    [No Abstract]   [Full Text] [Related]  

  • 7. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers.
    Sajjan US; Sun L; Goldstein R; Forstner JF
    J Bacteriol; 1995 Feb; 177(4):1030-8. PubMed ID: 7532166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
    Sajjan US; Corey M; Karmali MA; Forstner JF
    J Clin Invest; 1992 Feb; 89(2):648-56. PubMed ID: 1371125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?
    Butler SL; Doherty CJ; Hughes JE; Nelson JW; Govan JR
    J Clin Microbiol; 1995 Apr; 33(4):1001-4. PubMed ID: 7540623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular aspects of Burkholderia cepacia infection.
    Mohr CD; Tomich M; Herfst CA
    Microbes Infect; 2001 Apr; 3(5):425-35. PubMed ID: 11369280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.
    Segonds C; Chabanon G; Couetdic G; Michel-Briand Y; Bingen E
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):841-2. PubMed ID: 8950569
    [No Abstract]   [Full Text] [Related]  

  • 12. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia.
    Goldstein R; Sun L; Jiang RZ; Sajjan U; Forstner JF; Campanelli C
    J Bacteriol; 1995 Feb; 177(4):1039-52. PubMed ID: 7532167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomially acquired Pseudomonas cepacia infection in patients with cystic fibrosis.
    Tablan OC
    Infect Control Hosp Epidemiol; 1993 Mar; 14(3):124-6. PubMed ID: 7683030
    [No Abstract]   [Full Text] [Related]  

  • 14. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
    Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
    J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
    Segonds C; Chabanon G
    Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
    Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
    Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas cepacia at summer camps for persons with cystic fibrosis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jun; 42(23):456-9. PubMed ID: 7684813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pandoraea sputorum colonization in a patient with cystic fibrosis].
    Martínez-Lamas L; Rabade Castedo C; Martín Romero Domínguez M; Barbeito Castiñeiras G; Palacios Bartolomé A; Pérez Del Molino Bernal ML
    Arch Bronconeumol; 2011 Nov; 47(11):571-4. PubMed ID: 21908092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical management of cystic fibrosis.
    Elborn JS
    Chron Respir Dis; 2006; 3(3):161-5. PubMed ID: 16916010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.